Company name Rockwell Medical, Inc.
Stock symbol RMTI
Status Under Investigation

NEW YORK, May 24, 2018 – Bragar Eagel & Squire, P.C. is investigating potential claims against Rockwell Medical, Inc. (NASDAQ: RMTI).  Our investigation concerns whether Rockwell Medical has violated the federal securities laws and/or engaged in other unlawful business practices.

On May 22, 2018, after the market had closed, Rockwell Medical announced that the Company’s President and Chief Executive Officer, Robert Chioini, had been terminated from his positions, effective immediately.

However, on May 23, 2018, a letter was published by the Company, signed by Mr. Chioini, explaining that he had called an emergency Board meeting for the purpose of discussing alleged breaches of fiduciary duties and other possible violations of securities laws by various directors the Company.  The letter further asserted that those directors whose conduct was the subject of the alleged breaches of fiduciary duties voted to fire Mr. Chioini.

Following this news, Nasdaq suspended trading of Rockwell Medical securities.

If you purchased or otherwise acquired Rockwell Medical shares and suffered a loss, continue to hold shares, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at, or telephone at (212) 355-4648, or by filling out the contact form below. There is no cost or obligation to you.

First name*

Last name*

City, state, ZIP code

Email address*

Daytime phone

Evening phone

Purchase Date

No. of Shares

Purchase Price

Purchase Date

No. of Shares

Purchase Price

Join action?

Call to provide more information: Tel: (212) 308-4648

Please list below any additional transactions in this security:

Additional comments

The submission of this form does not create an attorney-client relationship, nor any obligation on the part of Bragar Eagel & Squire, P.C., or you to file a legal action. Any information you submit will be maintained as confidential. If Bragar Eagel & Squire, P.C., in its sole discretion, believes that you might be an appropriate class representative, Bragar Eagel & Squire, P.C., will contact you to discuss the matter and to determine whether to establish an attorney client relationship.